OGNT yields 200000000.00% · JNJ yields 2.13%● Live data
📍 OGNT pulled ahead of the other in Year 1
Combined, OGNT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OGNT + JNJ for your $10,000?
Organa Technologies Group, Inc., through its subsidiaries, provides technology-based solutions and consulting, computer hardware and software solutions, Internet-based retail sales, and other ancillary services. The company provides Internet Web hosting and voice over Internet protocol services; Web design services, hardware and software installation and training, and other Internet related consulting services; hardware and software computer system solutions and services; and on-line payment processing through ACH and other banking solutions. It also offers online product registration of replica weapons, and authentication through G2G online product registration of replica memorabilia, as well as enables Internet purchasing of swords and weapon memorabilia. The company was formerly known as Integrity Messenger Corporation and changed its name to Organa Technologies Group, Inc. in April, 2006. Organa Technologies Group, Inc. was founded in 2002 and is based in Melbourne, Florida.
Full OGNT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.